J. Bousquet

Publications1,574
h-index147
Citations96,472
Highly Influential Citations2,448
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • C. Bachert
  • 1,046 Publications • 48,412 Citations
  • P. Demoly
  • 820 Publications • 37,285 Citations
  • G. Canonica
  • 1,070 Publications • 39,184 Citations
  • T. Haahtela
  • 610 Publications • 34,162 Citations
  • Publications
  • Influence
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 *
TLDR
The Zar Review Group: I.J. Bousquet, N. Khaltaev, A. R. Rabe, J. Rosado-Pinto, G. Scadding, F. Simons, E. Togias, T. Valovirta, P. Vandenplas, D. Wang, M. Stoloff, O. Williams. Expand
Global strategy for asthma management and prevention: GINA executive summary
TLDR
It is reasonable to expect that in most patients with asthma, control of the disease can and should be achieved and maintained, and the Global Initiative for Asthma recommends a change in approach to asthma management, with asthma control, rather than asthma severity, being the focus of treatment decisions. Expand
Allergic rhinitis and its impact on asthma.
TLDR
This systematic review and meta-analyses confirmed the findings of a previous study published in “Rhinitis and Asthma: Causes and Prevention, 2nd Ed.” (2015) as well as new findings of “Mechanisms of Respiratory Disease and Allergology,” which confirmed the role of EMTs in the development of these diseases. Expand
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision.
TLDR
These are the most recent and currently the most systematically and transparently developed recommendations about the treatment of allergic rhinitis in adults and children and patients are encouraged to use these recommendations in their daily practice and to support their decisions. Expand
Asthma. From bronchoconstriction to airways inflammation and remodeling.
TLDR
This work has shown that chronic inflammation in the different forms of Asthma can affect both the severity and duration of the symptoms of the disease and the treatment options for these conditions vary greatly. Expand
Identifying 'well-controlled' and 'not well-controlled' asthma using the Asthma Control Questionnaire.
TLDR
Knowing the cut-points on the ACQ will enhance practising clinicians ability to identify patients whose asthma requires additional treatment, enable investigators to enroll poorly controlled patients into studies and for both clinicians and investigators to evaluate whether treatment goals are being achieved. Expand
A revised nomenclature for allergy: An EAACI position statement from the EAACI nomenclature task force
TLDR
The aim of this report is to propose a revised nomenclature for allergic and related reactions that can be used independently of target organ or patient age group. Expand
Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE
TLDR
The effect of omalizumab on clinically significant asthma exacerbations (requiring systemic corticosteroids) is determined in the first omalIZumab study to exclusively enrol patients from this difficult‐to‐treat patient population. Expand
Eosinophilic inflammation in asthma.
TLDR
Eosinophilic inflammation of the airways is correlated with the severity of asthma and these cells are likely to play a part in the epithelial damage seen in this disease. Expand
Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study.
TLDR
A 1-year, randomized, stratified, double-blind, parallel-group study of 3,421 patients with uncontrolled asthma, confirming that the goal of guideline-derived asthma control was achieved in a majority of the patients. Expand
...
1
2
3
4
5
...